Skip to main content
logo
SK bioscience Co.,Ltd. (KRX:302440)
South Korea flag South Korea · Delayed Price · Currency is KRW
50,200
-200 (-0.40%)
At close: Feb 11, 2026

Revenue by Product

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Vaccines and Biopharmaceuticals
267.55B
Vaccines and Biopharmaceuticals Growth
-27.59%

Revenue by Geography

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
South Korea
131.49B
South Korea Growth
-16.89%
Europe
107.12B
Europe Growth
405.26%
America
24.80B
America Growth
-86.66%
Asia
3.55B
Asia Growth
-8.81%
Middle East
576.98M
Middle East Growth
149.11%